Made effortsy HIV / AIDS Report summarizes reports lue artikkeli.

Made effortsy HIV / AIDS Report summarizes reports, initiatives from the International AIDS Conference – Aug. 8As part of the expanded coverage of the XVII International AIDS Conference, currently currently By August the 8th August will be be held in Mexico City, the Kaiser Daily HIV / AIDS Report offer studies and initiatives at the conference released lue artikkeli . Of selected publications of selected publications and initiatives below. – ‘The Changing HIV / AIDS Landscape, ‘World Bank: The report examines how the HIV / AIDS pandemic and the environment are rapidly changing and says that a localized, evidence-based response to the disease in Africa is required. It also deals with various issues – including the transmission dynamics, economic development and financial sustainability of HIV / AIDS interventions. – ‘Highly active antiretroviral therapy and survival in HIV-infected drug users, ‘Journal of the American Medical Association: Julio Montaner of the British Columbia Centre for Excellence in HIV / AIDS and colleagues conducted the study , the survival rate in HIV compare-positive individuals initiating HAART with and without a history of injection drug use.4 percent were IDUs, 579 or 18.6 percent were women and the average age was 39, HAART was between 1st August 1996 and 30 Initiated in June 2006, and the researchers followed the participants until 30 June 2007. They found that 622 participants died during the study – 232 of which were IDU and 390 of which were non – IDUs. In addition, at 84 months after the start of HAART, the researchers found similar mortality rates among IDUs and IDUs not. They concluded that in the study population, drug use has not been initiated with a decreased survival in HIV-positive HAART connected. Will work to’HIV prevalence estimates of the Demographic and Health Surveys, ‘MEASURE DHS: The of the of the population-based HIV in 28 countries in 28 countries with more than 400,000 men and women. Measure DHS project, starting in 2001, including HIV blood tests in its national surveys readjust what some experts international estimates of HIV prevalence. The report also examines the international burden of HIV / AIDS with a prevalence estimates ranging from less than 1 percent in Asia and West Africa to nearly 26 percent in Swaziland. MEASURE DHS has also released reports on Azerbaijan, Liberia, Pakistan and Swaziland . – ‘New advocacy organization for the Global Fund launched in Latin America, ‘Global Fund to Fight AIDS, Tuberculosis and Malaria: A new group – called Friends of the Global Fund Latin America – was launched at the AIDS conference to to promote the work of the Global Fund in the region. The group is based in Bogota, Colombia, and will work to a nine month sector in the financing of programs supported by the Global Fund to promote. The Global Fund has provided antiretroviral treatment to 100,000 people with HIV / AIDS and HIV testing and counseling, 2 million people in the region available.

The Power of Participation: Women Leaders Speak . UNIFEM / Athena Network: Although there have been calls for increased women participation in HIV / AIDS was repeated efforts, says the report by UNIFEM and Athena that women have full participation in the response implemented is still not on the disease. The report is based on a nine-month global review of existing documentation and interviews with participants. It provides a roadmap for action with recommendations for the promotion of women’s leadership in the fight against HIV / AIDS worldwide . J Kaisernetwork.org is the official webcaster of the XVII International AIDS Conference in Mexico City. Click here to register. For your Daily Update e-mail during the conference.

The average duration of treatment was 57 days. It was a DCR of 55 percent after eight weeks solid one condition had had 22 progressive sickness and 2 had an unknown reply , the ORR was to zero the median progression-free overall survival time was 83 days. , 6 percent of patients estimated to. Still progression-free shall be four months , the median overall survival was at time of at the time of evaluation.